slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 33,151-33,180
Pages 1,379
Rows per page 30
Component
33,151-33,180 of 41,369
20
Includes comparative data against Mogamulizumab (MAVORIC trial) and visual evidence of skin improvement.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
22
The slide uses a circular process diagram to show the feedback loop of immune cell activation and hair follicle damage.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
23
Includes photographic evidence of hair regrowth over 21 days and a bar chart showing fold reduction of NKG2D marker.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
25
Includes a blackbox warning text block as a competitive/safety barrier context.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
26
The slide outlines a clinical trial methodology and the strategic positioning of the drug candidate.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
28
Uses a contrast-based framing (750k patients vs 0 drugs) to establish market opportunity.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
29
The slide uses a four-column structure to explain the biological rationale, molecular nature, mechanism of action, and clinical status.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
30
Includes a heatmap showing gene expression profiles under different cytokine conditions.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
31
The slide uses a circular process diagram to show the mechanism of action and a bar chart to show efficacy.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
32
The slide uses a process-like flow to highlight the specific mechanism of action (IL-15/IL-21) compared to other approaches.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Loop · Why Now1 hit
37
Includes a disclaimer regarding the Form 10-Q and a footnote about debt facility prepayment.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
38
The slide uses a table-like structure to present clinical trial milestones and financial runway.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
08
The slide uses a biological process diagram to map drug assets to specific protein targets.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
13
The slide combines a biological pathway diagram (mechanism of action) with a clinical trial summary table.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
15
The slide highlights the poor efficacy of current SOC and suggests binimetinib as a superior alternative.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
18
Swimmer plot visualization of clinical trial data (Trial LXH254X2102).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
19
The slide highlights consistent clinical activity across two study phases, culminating in a combined ORR of 33.3%.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
21
The diagram uses a tree structure to categorize patient outcomes (off treatment vs on treatment, further broken down by SD and PR).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
36
The diagram shows the EGFR signaling pathway leading to MAPK and PI3K pathways.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
52
Data from HERKULES-1 study, cutoff 23 May 2022.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
53
The slide compares various dosing schedules (QW, BID-QW, BIW) against IC90 and IC50 thresholds.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
07
The slide uses a grid of product images as a background to reinforce the 'unique products' message.Etsy | Investor Presentation Deck | 34 slides · Etsy
Pitch deck Investor relations Beat · Solution1 hit
13
The slide uses a visual flow diagram to map marketing channels to the customer journey.Etsy | Investor Presentation Deck | 34 slides · Etsy
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
20
The chart shows a clear upward trend in GMS growth, moving from negative territory in early 2023 to positive growth by May and June.Etsy | Investor Presentation Deck | 34 slides · Etsy
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
22
The slide uses a split-background design to contrast new vs. reactivated buyer metrics.Etsy | Investor Presentation Deck | 34 slides · Etsy
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
25
Uses a nested box visualization to represent TAM, SAM, and SOM concepts.Etsy | Investor Presentation Deck | 34 slides · Etsy
Pitch deck Investor relations Beat · Market Size1 hit
27
The slide uses a temple metaphor to represent the company's ESG strategy.Etsy | Investor Presentation Deck | 34 slides · Etsy
Pitch deck Investor relations Beat · TeamLoop · Voice Of Customer1 hit
13
The slide uses a timeline-based process flow to illustrate efficiency goals.Etsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations Beat · Desire1 hit
19
Includes a callout for 4-year CAGR of Adjusted EBITDA.Etsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
25
The chart visualizes a recovery trend in GMS growth.Etsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations Loop · So What Cascade1 hit